Skip to search formSkip to main contentSkip to account menu

quinaprilat

Known as: (3S)-2-((S)-N-((S)-1-Carboxy-3-Phenylpropyl)Alanyl)-1,2,3,4-Tetrahydro-3-Isoquinolinecarboxylic Acid, 2-(2-((1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, 3-Isoquinolinecarboxylic Acid, 2-(2-((1-Carboxy-3-Phenylpropyl)Amino)-1-Oxopropyl)-1,2,3,4-Tetrahydro-, (3S-(2(R*(R*)),3R*))- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of… 
2011
2011
  • 2011
  • Corpus ID: 52000484
CLINICAL PHARMACOLOGY Mechanism of Action: Quinapril is deesterified to the principal metabolite, quinaprilat, which is an… 
2009
2009
Ljiljana LAUSEVIC-VUK Sazetak Analizirali smo hemodinamicke efekte intravenske primcnc inhibitora angiotenzin-konvertujuceg… 
2009
2009
1. Budavari S, editors. The Merck index. 13th ed. Whitehouse Station, NJ: Merck and Co., Inc.; 2001. 2. Freerd AL, Steven B… 
2000
2000
To the Editor: The study by Fabre et al,1 which demonstrates that tissue inhibition of angiotensin-converting enzyme (ACE… 
1991
1991
Quinapril, an inhibitor of angiotensin-converting enzyme (ACE) and an antihypertensive agent, was evaluated in rats for effects…